SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- Biocept, Inc.
(Nasdaq: BIOC), a leading commercial provider of molecular
diagnostic assays, products and services designed to provide
physicians with clinically actionable information to improve
patient outcomes, announces that President and CEO Michael Nall will present at the H.C. Wainwright
Virtual BioConnect Conference being held January 11-14, 2021. The presentation can
be accessed on the Investor Relations section of the Biocept
website beginning on January 11, 2021
at 6:00 a.m. Eastern time.
Mr. Nall will also participate in a panel discussion on
diagnostics and devices hosted by Scott
Gottlieb, M.D., former Food and Drug Administration (FDA)
Commissioner and former Centers for Medicare & Medicaid
Services (CMS) Senior Advisor. The panel will be held
Tuesday, January 12, 2021 at
12:00 p.m. Eastern time. The
panel presentation will be available live and through the remainder
of the conference, and can be accessed by registering for the H.C.
Wainwright BioConnect Conference here.
About Biocept
Biocept, Inc. is a molecular diagnostics
company with commercialized assays for lung, breast, gastric,
colorectal and prostate cancers, and melanoma. The Company uses its
proprietary liquid biopsy technology to provide physicians with
clinically actionable information for treating and monitoring
patients diagnosed with cancer. The Company's patented Target
Selector™ liquid biopsy technology platform captures and analyzes
tumor-associated molecular markers in both circulating tumor cells
(CTCs) and in circulating tumor DNA (ctDNA). With thousands of
tests performed, the platform has demonstrated the ability to
identify cancer mutations and alterations to inform physicians
about a patient's disease and therapeutic options.
Additionally, Biocept is offering nationwide COVID-19
polymerase chain reaction (PCR) testing to support public health
efforts during this unprecedented pandemic. For more
information, please visit www.biocept.com.
Investor Contact:
LHA Investor
Relations
Jody Cain
Jcain@lhai.com
310-691-7100
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biocept-to-present-at-hc-wainwright-virtual-bioconnect-conference-301199846.html
SOURCE Biocept, Inc.